0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Hepatitis B Virus Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17A14233
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Chronic Hepatitis B Virus Testing Market Research Report 2023
BUY CHAPTERS

Global Chronic Hepatitis B Virus Testing Market Research Report 2025

Code: QYRE-Auto-17A14233
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chronic Hepatitis B Virus Testing Market Size

The global market for Chronic Hepatitis B Virus Testing was valued at US$ 976 million in the year 2024 and is projected to reach a revised size of US$ 1547 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Chronic Hepatitis B Virus Testing Market

Chronic Hepatitis B Virus Testing Market

Chronic Hepatitis B Virus (HBV) testing refers to a series of laboratory tests that detect the presence of the virus in the blood over an extended period. Chronic hepatitis B is a condition in which the HBV infection lasts for more than six months.
North American market for Chronic Hepatitis B Virus Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Chronic Hepatitis B Virus Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Chronic Hepatitis B Virus Testing include Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Hepatitis B Virus Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Hepatitis B Virus Testing.
The Chronic Hepatitis B Virus Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Hepatitis B Virus Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Hepatitis B Virus Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chronic Hepatitis B Virus Testing Market Report

Report Metric Details
Report Name Chronic Hepatitis B Virus Testing Market
Accounted market size in year US$ 976 million
Forecasted market size in 2031 US$ 1547 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Chronic Hepatitis B Virus Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Chronic Hepatitis B Virus Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Chronic Hepatitis B Virus Testing Market growing?

Ans: The Chronic Hepatitis B Virus Testing Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Chronic Hepatitis B Virus Testing Market size in 2031?

Ans: The Chronic Hepatitis B Virus Testing Market size in 2031 will be US$ 1547 million.

Who are the main players in the Chronic Hepatitis B Virus Testing Market report?

Ans: The main players in the Chronic Hepatitis B Virus Testing Market are Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience

What are the Application segmentation covered in the Chronic Hepatitis B Virus Testing Market report?

Ans: The Applications covered in the Chronic Hepatitis B Virus Testing Market report are Hospitals, Clinics, Diagnostic Centers, Home

What are the Type segmentation covered in the Chronic Hepatitis B Virus Testing Market report?

Ans: The Types covered in the Chronic Hepatitis B Virus Testing Market report are Enzyme Immunoassay Kits, Hepatitis B Surface Antigen Test, Anti-Hepatitis B Surface Antibody Test, Anti-Hepatitis B Core Antibody Test, Point-of-Care Testing Kits

Recommended Reports

Hepatitis B Markets

Virus Diagnostics

Liver Disease Therapy

1 Chronic Hepatitis B Virus Testing Market Overview
1.1 Product Definition
1.2 Chronic Hepatitis B Virus Testing by Type
1.2.1 Global Chronic Hepatitis B Virus Testing Market Value Comparison by Type (2024 VS 2031)
1.2.2 Enzyme Immunoassay Kits
1.2.3 Hepatitis B Surface Antigen Test
1.2.4 Anti-Hepatitis B Surface Antibody Test
1.2.5 Anti-Hepatitis B Core Antibody Test
1.2.6 Point-of-Care Testing Kits
1.3 Chronic Hepatitis B Virus Testing by Application
1.3.1 Global Chronic Hepatitis B Virus Testing Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Home
1.4 Global Chronic Hepatitis B Virus Testing Market Size Estimates and Forecasts
1.4.1 Global Chronic Hepatitis B Virus Testing Revenue 2020-2031
1.4.2 Global Chronic Hepatitis B Virus Testing Sales 2020-2031
1.4.3 Global Chronic Hepatitis B Virus Testing Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Chronic Hepatitis B Virus Testing Market Competition by Manufacturers
2.1 Global Chronic Hepatitis B Virus Testing Sales Market Share by Manufacturers (2020-2025)
2.2 Global Chronic Hepatitis B Virus Testing Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Chronic Hepatitis B Virus Testing Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Chronic Hepatitis B Virus Testing, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Hepatitis B Virus Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Hepatitis B Virus Testing, Product Type & Application
2.7 Global Key Manufacturers of Chronic Hepatitis B Virus Testing, Date of Enter into This Industry
2.8 Global Chronic Hepatitis B Virus Testing Market Competitive Situation and Trends
2.8.1 Global Chronic Hepatitis B Virus Testing Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Chronic Hepatitis B Virus Testing Players Market Share by Revenue
2.8.3 Global Chronic Hepatitis B Virus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chronic Hepatitis B Virus Testing Market Scenario by Region
3.1 Global Chronic Hepatitis B Virus Testing Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Chronic Hepatitis B Virus Testing Sales by Region: 2020-2031
3.2.1 Global Chronic Hepatitis B Virus Testing Sales by Region: 2020-2025
3.2.2 Global Chronic Hepatitis B Virus Testing Sales by Region: 2026-2031
3.3 Global Chronic Hepatitis B Virus Testing Revenue by Region: 2020-2031
3.3.1 Global Chronic Hepatitis B Virus Testing Revenue by Region: 2020-2025
3.3.2 Global Chronic Hepatitis B Virus Testing Revenue by Region: 2026-2031
3.4 North America Chronic Hepatitis B Virus Testing Market Facts & Figures by Country
3.4.1 North America Chronic Hepatitis B Virus Testing Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Chronic Hepatitis B Virus Testing Sales by Country (2020-2031)
3.4.3 North America Chronic Hepatitis B Virus Testing Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Hepatitis B Virus Testing Market Facts & Figures by Country
3.5.1 Europe Chronic Hepatitis B Virus Testing Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Chronic Hepatitis B Virus Testing Sales by Country (2020-2031)
3.5.3 Europe Chronic Hepatitis B Virus Testing Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Hepatitis B Virus Testing Market Facts & Figures by Region
3.6.1 Asia Pacific Chronic Hepatitis B Virus Testing Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Chronic Hepatitis B Virus Testing Sales by Region (2020-2031)
3.6.3 Asia Pacific Chronic Hepatitis B Virus Testing Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chronic Hepatitis B Virus Testing Market Facts & Figures by Country
3.7.1 Latin America Chronic Hepatitis B Virus Testing Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Chronic Hepatitis B Virus Testing Sales by Country (2020-2031)
3.7.3 Latin America Chronic Hepatitis B Virus Testing Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Hepatitis B Virus Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Hepatitis B Virus Testing Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Chronic Hepatitis B Virus Testing Sales by Country (2020-2031)
3.8.3 Middle East and Africa Chronic Hepatitis B Virus Testing Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Hepatitis B Virus Testing Sales by Type (2020-2031)
4.1.1 Global Chronic Hepatitis B Virus Testing Sales by Type (2020-2025)
4.1.2 Global Chronic Hepatitis B Virus Testing Sales by Type (2026-2031)
4.1.3 Global Chronic Hepatitis B Virus Testing Sales Market Share by Type (2020-2031)
4.2 Global Chronic Hepatitis B Virus Testing Revenue by Type (2020-2031)
4.2.1 Global Chronic Hepatitis B Virus Testing Revenue by Type (2020-2025)
4.2.2 Global Chronic Hepatitis B Virus Testing Revenue by Type (2026-2031)
4.2.3 Global Chronic Hepatitis B Virus Testing Revenue Market Share by Type (2020-2031)
4.3 Global Chronic Hepatitis B Virus Testing Price by Type (2020-2031)
5 Segment by Application
5.1 Global Chronic Hepatitis B Virus Testing Sales by Application (2020-2031)
5.1.1 Global Chronic Hepatitis B Virus Testing Sales by Application (2020-2025)
5.1.2 Global Chronic Hepatitis B Virus Testing Sales by Application (2026-2031)
5.1.3 Global Chronic Hepatitis B Virus Testing Sales Market Share by Application (2020-2031)
5.2 Global Chronic Hepatitis B Virus Testing Revenue by Application (2020-2031)
5.2.1 Global Chronic Hepatitis B Virus Testing Revenue by Application (2020-2025)
5.2.2 Global Chronic Hepatitis B Virus Testing Revenue by Application (2026-2031)
5.2.3 Global Chronic Hepatitis B Virus Testing Revenue Market Share by Application (2020-2031)
5.3 Global Chronic Hepatitis B Virus Testing Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Sciences Chronic Hepatitis B Virus Testing Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Chronic Hepatitis B Virus Testing Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Ionis Pharma
6.3.1 Ionis Pharma Company Information
6.3.2 Ionis Pharma Description and Business Overview
6.3.3 Ionis Pharma Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ionis Pharma Chronic Hepatitis B Virus Testing Product Portfolio
6.3.5 Ionis Pharma Recent Developments/Updates
6.4 Janssen Sciences Ireland
6.4.1 Janssen Sciences Ireland Company Information
6.4.2 Janssen Sciences Ireland Description and Business Overview
6.4.3 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product Portfolio
6.4.5 Janssen Sciences Ireland Recent Developments/Updates
6.5 Assembly Biosciences
6.5.1 Assembly Biosciences Company Information
6.5.2 Assembly Biosciences Description and Business Overview
6.5.3 Assembly Biosciences Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Assembly Biosciences Chronic Hepatitis B Virus Testing Product Portfolio
6.5.5 Assembly Biosciences Recent Developments/Updates
6.6 Janssen and Arrowhead Pharmaceuticals
6.6.1 Janssen and Arrowhead Pharmaceuticals Company Information
6.6.2 Janssen and Arrowhead Pharmaceuticals Description and Business Overview
6.6.3 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product Portfolio
6.6.5 Janssen and Arrowhead Pharmaceuticals Recent Developments/Updates
6.7 Roche
6.7.1 Roche Company Information
6.7.2 Roche Description and Business Overview
6.7.3 Roche Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Roche Chronic Hepatitis B Virus Testing Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Vir Biotechnology
6.8.1 Vir Biotechnology Company Information
6.8.2 Vir Biotechnology Description and Business Overview
6.8.3 Vir Biotechnology Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vir Biotechnology Chronic Hepatitis B Virus Testing Product Portfolio
6.8.5 Vir Biotechnology Recent Developments/Updates
6.9 Bio-Rad Laboratories, Inc.
6.9.1 Bio-Rad Laboratories, Inc. Company Information
6.9.2 Bio-Rad Laboratories, Inc. Description and Business Overview
6.9.3 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product Portfolio
6.9.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
6.10 DiaSorin S.p.A.
6.10.1 DiaSorin S.p.A. Company Information
6.10.2 DiaSorin S.p.A. Description and Business Overview
6.10.3 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product Portfolio
6.10.5 DiaSorin S.p.A. Recent Developments/Updates
6.11 Abbott Laboratories
6.11.1 Abbott Laboratories Company Information
6.11.2 Abbott Laboratories Description and Business Overview
6.11.3 Abbott Laboratories Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Abbott Laboratories Chronic Hepatitis B Virus Testing Product Portfolio
6.11.5 Abbott Laboratories Recent Developments/Updates
6.12 Meridian Bioscience
6.12.1 Meridian Bioscience Company Information
6.12.2 Meridian Bioscience Description and Business Overview
6.12.3 Meridian Bioscience Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Meridian Bioscience Chronic Hepatitis B Virus Testing Product Portfolio
6.12.5 Meridian Bioscience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Hepatitis B Virus Testing Industry Chain Analysis
7.2 Chronic Hepatitis B Virus Testing Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Hepatitis B Virus Testing Production Mode & Process Analysis
7.4 Chronic Hepatitis B Virus Testing Sales and Marketing
7.4.1 Chronic Hepatitis B Virus Testing Sales Channels
7.4.2 Chronic Hepatitis B Virus Testing Distributors
7.5 Chronic Hepatitis B Virus Testing Customer Analysis
8 Chronic Hepatitis B Virus Testing Market Dynamics
8.1 Chronic Hepatitis B Virus Testing Industry Trends
8.2 Chronic Hepatitis B Virus Testing Market Drivers
8.3 Chronic Hepatitis B Virus Testing Market Challenges
8.4 Chronic Hepatitis B Virus Testing Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Chronic Hepatitis B Virus Testing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Chronic Hepatitis B Virus Testing Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Chronic Hepatitis B Virus Testing Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Chronic Hepatitis B Virus Testing Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Chronic Hepatitis B Virus Testing Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Chronic Hepatitis B Virus Testing Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Chronic Hepatitis B Virus Testing Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Chronic Hepatitis B Virus Testing Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Chronic Hepatitis B Virus Testing, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Chronic Hepatitis B Virus Testing, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Chronic Hepatitis B Virus Testing, Product Type & Application
 Table 12. Global Key Manufacturers of Chronic Hepatitis B Virus Testing, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Chronic Hepatitis B Virus Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Virus Testing as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Chronic Hepatitis B Virus Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Chronic Hepatitis B Virus Testing Sales by Region (2020-2025) & (K Units)
 Table 18. Global Chronic Hepatitis B Virus Testing Sales Market Share by Region (2020-2025)
 Table 19. Global Chronic Hepatitis B Virus Testing Sales by Region (2026-2031) & (K Units)
 Table 20. Global Chronic Hepatitis B Virus Testing Sales Market Share by Region (2026-2031)
 Table 21. Global Chronic Hepatitis B Virus Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Region (2020-2025)
 Table 23. Global Chronic Hepatitis B Virus Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Region (2026-2031)
 Table 25. North America Chronic Hepatitis B Virus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Chronic Hepatitis B Virus Testing Sales by Country (2020-2025) & (K Units)
 Table 27. North America Chronic Hepatitis B Virus Testing Sales by Country (2026-2031) & (K Units)
 Table 28. North America Chronic Hepatitis B Virus Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Chronic Hepatitis B Virus Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Chronic Hepatitis B Virus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Chronic Hepatitis B Virus Testing Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Chronic Hepatitis B Virus Testing Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Chronic Hepatitis B Virus Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Chronic Hepatitis B Virus Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Chronic Hepatitis B Virus Testing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Chronic Hepatitis B Virus Testing Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Chronic Hepatitis B Virus Testing Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Chronic Hepatitis B Virus Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Chronic Hepatitis B Virus Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Chronic Hepatitis B Virus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Chronic Hepatitis B Virus Testing Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Chronic Hepatitis B Virus Testing Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Chronic Hepatitis B Virus Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Chronic Hepatitis B Virus Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Chronic Hepatitis B Virus Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Chronic Hepatitis B Virus Testing Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Chronic Hepatitis B Virus Testing Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Chronic Hepatitis B Virus Testing Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Chronic Hepatitis B Virus Testing Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Chronic Hepatitis B Virus Testing Sales (K Units) by Type (2020-2025)
 Table 51. Global Chronic Hepatitis B Virus Testing Sales (K Units) by Type (2026-2031)
 Table 52. Global Chronic Hepatitis B Virus Testing Sales Market Share by Type (2020-2025)
 Table 53. Global Chronic Hepatitis B Virus Testing Sales Market Share by Type (2026-2031)
 Table 54. Global Chronic Hepatitis B Virus Testing Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Chronic Hepatitis B Virus Testing Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Type (2020-2025)
 Table 57. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Type (2026-2031)
 Table 58. Global Chronic Hepatitis B Virus Testing Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Chronic Hepatitis B Virus Testing Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Chronic Hepatitis B Virus Testing Sales (K Units) by Application (2020-2025)
 Table 61. Global Chronic Hepatitis B Virus Testing Sales (K Units) by Application (2026-2031)
 Table 62. Global Chronic Hepatitis B Virus Testing Sales Market Share by Application (2020-2025)
 Table 63. Global Chronic Hepatitis B Virus Testing Sales Market Share by Application (2026-2031)
 Table 64. Global Chronic Hepatitis B Virus Testing Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Chronic Hepatitis B Virus Testing Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Application (2020-2025)
 Table 67. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Application (2026-2031)
 Table 68. Global Chronic Hepatitis B Virus Testing Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Chronic Hepatitis B Virus Testing Price (US$/Unit) by Application (2026-2031)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Gilead Sciences Chronic Hepatitis B Virus Testing Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Chronic Hepatitis B Virus Testing Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Ionis Pharma Company Information
 Table 81. Ionis Pharma Description and Business Overview
 Table 82. Ionis Pharma Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Ionis Pharma Chronic Hepatitis B Virus Testing Product
 Table 84. Ionis Pharma Recent Developments/Updates
 Table 85. Janssen Sciences Ireland Company Information
 Table 86. Janssen Sciences Ireland Description and Business Overview
 Table 87. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product
 Table 89. Janssen Sciences Ireland Recent Developments/Updates
 Table 90. Assembly Biosciences Company Information
 Table 91. Assembly Biosciences Description and Business Overview
 Table 92. Assembly Biosciences Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Assembly Biosciences Chronic Hepatitis B Virus Testing Product
 Table 94. Assembly Biosciences Recent Developments/Updates
 Table 95. Janssen and Arrowhead Pharmaceuticals Company Information
 Table 96. Janssen and Arrowhead Pharmaceuticals Description and Business Overview
 Table 97. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product
 Table 99. Janssen and Arrowhead Pharmaceuticals Recent Developments/Updates
 Table 100. Roche Company Information
 Table 101. Roche Description and Business Overview
 Table 102. Roche Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Roche Chronic Hepatitis B Virus Testing Product
 Table 104. Roche Recent Developments/Updates
 Table 105. Vir Biotechnology Company Information
 Table 106. Vir Biotechnology Description and Business Overview
 Table 107. Vir Biotechnology Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Vir Biotechnology Chronic Hepatitis B Virus Testing Product
 Table 109. Vir Biotechnology Recent Developments/Updates
 Table 110. Bio-Rad Laboratories, Inc. Company Information
 Table 111. Bio-Rad Laboratories, Inc. Description and Business Overview
 Table 112. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product
 Table 114. Bio-Rad Laboratories, Inc. Recent Developments/Updates
 Table 115. DiaSorin S.p.A. Company Information
 Table 116. DiaSorin S.p.A. Description and Business Overview
 Table 117. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product
 Table 119. DiaSorin S.p.A. Recent Developments/Updates
 Table 120. Abbott Laboratories Company Information
 Table 121. Abbott Laboratories Description and Business Overview
 Table 122. Abbott Laboratories Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Abbott Laboratories Chronic Hepatitis B Virus Testing Product
 Table 124. Abbott Laboratories Recent Developments/Updates
 Table 125. Meridian Bioscience Company Information
 Table 126. Meridian Bioscience Description and Business Overview
 Table 127. Meridian Bioscience Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Meridian Bioscience Chronic Hepatitis B Virus Testing Product
 Table 129. Meridian Bioscience Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Chronic Hepatitis B Virus Testing Distributors List
 Table 133. Chronic Hepatitis B Virus Testing Customers List
 Table 134. Chronic Hepatitis B Virus Testing Market Trends
 Table 135. Chronic Hepatitis B Virus Testing Market Drivers
 Table 136. Chronic Hepatitis B Virus Testing Market Challenges
 Table 137. Chronic Hepatitis B Virus Testing Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Chronic Hepatitis B Virus Testing
 Figure 2. Global Chronic Hepatitis B Virus Testing Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chronic Hepatitis B Virus Testing Market Share by Type: 2024 & 2031
 Figure 4. Enzyme Immunoassay Kits Product Picture
 Figure 5. Hepatitis B Surface Antigen Test Product Picture
 Figure 6. Anti-Hepatitis B Surface Antibody Test Product Picture
 Figure 7. Anti-Hepatitis B Core Antibody Test Product Picture
 Figure 8. Point-of-Care Testing Kits Product Picture
 Figure 9. Global Chronic Hepatitis B Virus Testing Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Chronic Hepatitis B Virus Testing Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Clinics
 Figure 13. Diagnostic Centers
 Figure 14. Home
 Figure 15. Global Chronic Hepatitis B Virus Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Chronic Hepatitis B Virus Testing Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Chronic Hepatitis B Virus Testing Sales (2020-2031) & (K Units)
 Figure 18. Global Chronic Hepatitis B Virus Testing Average Price (US$/Unit) & (2020-2031)
 Figure 19. Chronic Hepatitis B Virus Testing Report Years Considered
 Figure 20. Chronic Hepatitis B Virus Testing Sales Share by Manufacturers in 2024
 Figure 21. Global Chronic Hepatitis B Virus Testing Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Chronic Hepatitis B Virus Testing Players: Market Share by Revenue in Chronic Hepatitis B Virus Testing in 2024
 Figure 23. Chronic Hepatitis B Virus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Chronic Hepatitis B Virus Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Chronic Hepatitis B Virus Testing Sales Market Share by Country (2020-2031)
 Figure 26. North America Chronic Hepatitis B Virus Testing Revenue Market Share by Country (2020-2031)
 Figure 27. United States Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Chronic Hepatitis B Virus Testing Sales Market Share by Country (2020-2031)
 Figure 30. Europe Chronic Hepatitis B Virus Testing Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Chronic Hepatitis B Virus Testing Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Chronic Hepatitis B Virus Testing Revenue Market Share by Region (2020-2031)
 Figure 38. China Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Chronic Hepatitis B Virus Testing Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Chronic Hepatitis B Virus Testing Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Chronic Hepatitis B Virus Testing Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Chronic Hepatitis B Virus Testing Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Chronic Hepatitis B Virus Testing Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Chronic Hepatitis B Virus Testing by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Chronic Hepatitis B Virus Testing by Type (2020-2031)
 Figure 57. Global Chronic Hepatitis B Virus Testing Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Chronic Hepatitis B Virus Testing by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Chronic Hepatitis B Virus Testing by Application (2020-2031)
 Figure 60. Global Chronic Hepatitis B Virus Testing Price (US$/Unit) by Application (2020-2031)
 Figure 61. Chronic Hepatitis B Virus Testing Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart